ES2436614T3 - Composiciones y procedimientos de tratamiento de bacterias - Google Patents

Composiciones y procedimientos de tratamiento de bacterias Download PDF

Info

Publication number
ES2436614T3
ES2436614T3 ES06813251.3T ES06813251T ES2436614T3 ES 2436614 T3 ES2436614 T3 ES 2436614T3 ES 06813251 T ES06813251 T ES 06813251T ES 2436614 T3 ES2436614 T3 ES 2436614T3
Authority
ES
Spain
Prior art keywords
nisin
mupirocin
bacteria
composition
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06813251.3T
Other languages
English (en)
Spanish (es)
Inventor
Scott Michael Walsh
Mary Catherine Pittaway
James J. Mond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosynexus Inc
Original Assignee
Biosynexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosynexus Inc filed Critical Biosynexus Inc
Application granted granted Critical
Publication of ES2436614T3 publication Critical patent/ES2436614T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES06813251.3T 2005-07-28 2006-07-28 Composiciones y procedimientos de tratamiento de bacterias Expired - Lifetime ES2436614T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US70301005P 2005-07-28 2005-07-28
US703010P 2005-07-28
US72519305P 2005-10-11 2005-10-11
US725193P 2005-10-11
US77903406P 2006-03-03 2006-03-03
US779034P 2006-03-03
PCT/US2006/029672 WO2007014372A2 (en) 2005-07-28 2006-07-28 Compositions and methods for treating bacteria

Publications (1)

Publication Number Publication Date
ES2436614T3 true ES2436614T3 (es) 2014-01-03

Family

ID=37684026

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06813251.3T Expired - Lifetime ES2436614T3 (es) 2005-07-28 2006-07-28 Composiciones y procedimientos de tratamiento de bacterias

Country Status (6)

Country Link
US (2) US7517852B2 (cg-RX-API-DMAC10.html)
EP (1) EP1940437B1 (cg-RX-API-DMAC10.html)
JP (1) JP5619352B2 (cg-RX-API-DMAC10.html)
CA (1) CA2617133C (cg-RX-API-DMAC10.html)
ES (1) ES2436614T3 (cg-RX-API-DMAC10.html)
WO (1) WO2007014372A2 (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617133C (en) * 2005-07-28 2014-09-30 Biosynexus Incorporated Compositions and methods for treating bacteria
WO2007044745A1 (en) * 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
WO2009032470A2 (en) * 2007-08-22 2009-03-12 Trustees Of Dartmouth College Compositions and methods for diagnosing and treating community-acquired methicillin-resistant staphylococcus aureus
EP2205074A4 (en) * 2007-10-04 2013-07-31 Harvard College MOENOMYCIN ANALOGUE, SYNTHESIS PROCESS AND USE
US20100008993A1 (en) * 2008-07-14 2010-01-14 Proksch Joel W Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs
JP5374260B2 (ja) * 2009-07-10 2013-12-25 静岡商工会議所 農業用資材
CN103189046B (zh) 2010-09-09 2016-09-07 玫琳凯有限公司 包含植物提取物的局部护肤制剂
JP2014500275A (ja) 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
WO2012125941A1 (en) * 2011-03-17 2012-09-20 Follica, Inc. Lithium treatment for microbial infections
TW201334696A (zh) * 2012-02-28 2013-09-01 Marrone Bio Innovations Inc 以假單胞菌防治植物病原微生物之方法與取自假單胞菌之物質及組成物
WO2013152279A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
US10106833B2 (en) 2012-04-06 2018-10-23 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2016044443A1 (en) * 2014-09-16 2016-03-24 Philip Demokritou Engineered water nanostructures (ewns) and uses thereof
US10617703B2 (en) * 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US12502370B2 (en) * 2019-04-11 2025-12-23 Cmpd Licensing, Llc Wound treatments and compositions
EP3331496B1 (en) * 2015-08-05 2021-01-27 The University of Rochester Antimicrobial compositions comprising mupirocin and neomycin
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018098152A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2019081309A1 (en) 2017-10-27 2019-05-02 OCE Holding B.V. MULTI-ROLL PRINTER CONTROL DEVICE, PRINTING SYSTEM, AND MULTI-ROLL PRINTER CONTROL METHOD
CA3128389A1 (en) * 2019-03-08 2020-09-17 Fraunhofer Usa, Inc. Novel antimicrobial lantibiotic peptide and uses thereof
US12156875B2 (en) * 2019-04-11 2024-12-03 Cmpd Licensing, Llc Wound treatments and compositions
CN114340605A (zh) * 2019-08-26 2022-04-12 肯特州立大学 合理设计的指甲花醌衍生物作为耐多药金黄色葡萄球菌的抗菌剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
US5260271A (en) 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
WO1992018633A1 (en) * 1991-04-11 1992-10-29 Stichting Nederlands Instituut Voor Zuivelonderzoek (Nizo) Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics
CA2169847C (en) 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis
GB9423404D0 (en) * 1994-11-19 1995-01-11 Biotech & Biolog Scien Res Production of nisin
US5866539A (en) 1995-06-23 1999-02-02 Ambi Inc. Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
US5928146A (en) * 1996-03-15 1999-07-27 Hitachi Medical Corporation Inspection apparatus using nuclear magnetic resonance
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
US20060140984A1 (en) * 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
BR0316776A (pt) * 2002-12-10 2005-10-25 Biosynexus Inc Formula para anti-infeccioso tópico
CA2617133C (en) * 2005-07-28 2014-09-30 Biosynexus Incorporated Compositions and methods for treating bacteria
WO2007044745A1 (en) * 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections

Also Published As

Publication number Publication date
JP5619352B2 (ja) 2014-11-05
CA2617133A1 (en) 2007-02-01
EP1940437A4 (en) 2009-08-19
US20090196945A1 (en) 2009-08-06
US20070060506A1 (en) 2007-03-15
JP2009502965A (ja) 2009-01-29
EP1940437A2 (en) 2008-07-09
CA2617133C (en) 2014-09-30
US8697639B2 (en) 2014-04-15
WO2007014372A2 (en) 2007-02-01
EP1940437B1 (en) 2013-09-04
WO2007014372A3 (en) 2007-07-26
US7517852B2 (en) 2009-04-14

Similar Documents

Publication Publication Date Title
US8697639B2 (en) Compositions and methods for treating bacteria
US20090304783A1 (en) Compositions and methods for treating bacteria
ES2565564T3 (es) Una composición que comprende un antibiótico y un dispersante
ES2201189T3 (es) Metodo para el control de bacterias gram positivas resistentes a antibioticos y tratamiento de la infeccion.
CA2508796A1 (en) Topical anti-infective formulations
US20210260101A1 (en) Potentiated antibiotic compositions and methods of use for treating bacterial infections and biofilms
AU2019288723A1 (en) Lysins and derivatives thereof resensitize Staphylococcus aureus and gram-positive bacteria to antibiotics
AU2011231112B2 (en) Compositions for topical administration
ES2274614T3 (es) Uso de un agente antimicrobiano, tal como la taurolidina o el taurultam, para preparar un medicamento para el tratamiento de una infeccion microbiana nosocomial.
CA2641854A1 (en) Neutralization of bacterial spores
CN118251216A (zh) 用于生物膜破坏的方法
EP2709644B1 (en) Compositions for use for treating a disorder associated with sequestered bacteria
ES2905979T3 (es) Composiciones antibacterianas
PT1458391E (pt) Um processo para tratamento de infecções bacterianas através do uso de gemifloxacina ou um seu sal e um antibiótico b-lactâmico
Shankar et al. Newer antibiotics
van Saene et al. A Possible Explanation for the Success of SDD
Gardam et al. Disinfectants and Antiseptics
Bébéar Pre-clinical Microbiology—Atypical Organisms
Gawande et al. Antibiofilm and Antimicrobial Efficacy of DispersinB (registered trademark)-KSL-W Peptide-Based Wound Gel Against Chronic Wound Infection Associated Bacteria
Wound Hyaluronic Acid Binding Peptides Prevent
AU2014200086A1 (en) Compositions for topical administration